© 2020 MJH Life Sciences and HCPLive. All rights reserved.
© 2020 MJH Life Sciences™ and HCPLive. All rights reserved.
November 24, 2020
More studies are planned testing the impact of finerenone.
Finerenone could be another option to SGLT2 inhibitors for this patient population.
About 20% of 81 positive patients experienced critical neurological complications; further, half had a pre-existing history of high blood pressure or type 2 diabetes.
Guidance based on procalcitonin concentration levels may useful in reducing duration of antibiotic treatment for sickle cell patients with acute chest syndrome.
Researchers present new data from the SUSTAIN 6 and PIONEER 6 trials during the virtual AHA 2020 conference.
The indication comes from collaborative work among experts and community leaders coordinated by the Oxalosis & Hyperoxaluria Foundation and the Kidney Health Initiative.
November 23, 2020
To date, 3 vaccine candidates with favorable safety profiles show promise in offering protection against COVID-19.
The rates of ALT normalization maintained in both arms of the 96 week study.
The newest indication coincides with growing concerns that COVID-19 and flu spread will cause unprecedented burden on the US this winter.
The lipid profile changes were not significant after 6 months, while the changes in the lipid profile are due to other factors and not the drugs.